TAJUANA TINNIN: Open Payments
NPI 1881125854 · ZIONSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,097 in 112 payments from 15 companies in 2025. Trend: 2023 $15,257 · 2024 $12,321 · 2025 $2,097
Food & beverage: $2,092Education: $5
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $463 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $255 |
| Vanda Pharmaceuticals Inc. | 9 | $254 |
| Indivior Inc. | 14 | $220 |
| Gilead Sciences, Inc. | 10 | $216 |
| Otsuka America Pharmaceutical, Inc. | 10 | $194 |
| Axsome Therapeutics, Inc. | 7 | $143 |
| Orexo US, Inc. | 7 | $115 |
| Braeburn Inc. | 3 | $53 |
| Tris Pharma Inc | 3 | $50 |
Products named: MAVYRET, CAPLYTA, HETLIOZ, SUBLOCADE, REXULTI, Auvelity, VRAYLAR, Zubsolv.
Industry payments across IN — which companies pay providers there.
